Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: Potential for adoptive cellular immunotherapy.

[1]  M. Berg,et al.  A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation. , 2015, Cytotherapy.

[2]  J. Madrigal,et al.  Natural Killer Cell Immunotherapy: From Bench to Bedside , 2015, Front. Immunol..

[3]  M. Czuczman,et al.  Targeting CD20+ Aggressive B-cell Non–Hodgkin Lymphoma by Anti-CD20 CAR mRNA-Modified Expanded Natural Killer Cells In Vitro and in NSG Mice , 2014, Cancer Immunology Research.

[4]  Elizabeth J. Shpall,et al.  Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity , 2013, PloS one.

[5]  J. Cany,et al.  Natural Killer Cells Generated from Cord Blood Hematopoietic Progenitor Cells Efficiently Target Bone Marrow-Residing Human Leukemia Cells in NOD/SCID/IL2Rgnull Mice , 2013, PloS one.

[6]  D. Campana,et al.  A chimeric receptor with NKG2D specificity enhances natural killer cell activation and killing of tumor cells. , 2013, Cancer research.

[7]  Xiao-Jie Yan,et al.  IGHV-unmutated and IGHV-mutated chronic lymphocytic leukemia cells produce activation-induced deaminase protein with a full range of biologic functions. , 2012, Blood.

[8]  T. Kondo,et al.  Expansion of NK cells from cord blood with antileukemic activity using GMP-compliant substances without feeder cells , 2012, Leukemia.

[9]  J. Jacobson,et al.  T cell depletion utilizing CD34+ stem cell selection and CD3+ addback from unrelated adult donors in paediatric allogeneic stem cell transplantation recipients , 2012, British journal of haematology.

[10]  Eric Vivier,et al.  Targeting natural killer cells and natural killer T cells in cancer , 2012, Nature Reviews Immunology.

[11]  D. Campana,et al.  Natural killer cell engineering for cellular therapy of cancer. , 2011, Tissue antigens.

[12]  J. Jacobson,et al.  A comparison of immune reconstitution and graft‐versus‐host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients , 2011, British journal of haematology.

[13]  Jeffrey S. Miller,et al.  NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. , 2011, Blood.

[14]  Harry Dolstra,et al.  Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process , 2011, PloS one.

[15]  M. Geyer,et al.  Cord blood transplantation and stem cell regenerative potential. , 2011, Experimental hematology.

[16]  J. Gribben,et al.  Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion , 2010, Journal of immunotherapy.

[17]  Lijun Xu,et al.  Quantitative analysis of cell tracing by in vivo imaging system , 2010, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.

[18]  D. Campana,et al.  Cytotoxicity of Activated Natural Killer Cells against Pediatric Solid Tumors , 2010, Clinical Cancer Research.

[19]  M. Verneris,et al.  The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells , 2009, British journal of haematology.

[20]  M. Cairo,et al.  Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy. , 2009, Experimental hematology.

[21]  D. Campana,et al.  Expansion of highly cytotoxic human natural killer cells for cancer cell therapy. , 2009, Cancer research.

[22]  D. Campana,et al.  Expansion and activation of natural killer cells for cancer immunotherapy. , 2009, The Korean journal of laboratory medicine.

[23]  J. Schold,et al.  The relationship between circulating natural killer cells after reduced intensity conditioning hematopoietic stem cell transplantation and relapse-free survival and graft-versus-host disease , 2008, Haematologica.

[24]  P. Hwu,et al.  Visualizing fewer than 10 mouse T cells with an enhanced firefly luciferase in immunocompetent mouse models of cancer , 2008, Proceedings of the National Academy of Sciences.

[25]  R. Negrin,et al.  In vivo trafficking and survival of cytokine-induced killer cells resulting in minimal GVHD with retention of antitumor activity. , 2008, Blood.

[26]  Jeffrey S. Miller,et al.  Use of natural killer cells as immunotherapy for leukaemia. , 2008, Best practice & research. Clinical haematology.

[27]  Chang‐you Wu,et al.  Phenotypic and Functional Heterogeneity of Natural Killer Cells from Umbilical Cord Blood Mononuclear Cells , 2008, Immunological investigations.

[28]  W. C. Brown,et al.  Correlation of the Highest-Energy Cosmic Rays with Nearby Extragalactic Objects , 2007, Science.

[29]  Richard Bancroft,et al.  Hypothenar Hammer Syndrome in Two Collegiate Athletes: Immediate Versus Delayed Surgical Treatment , 2007, Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine.

[30]  M. Cairo,et al.  Human natural killer cells in health and disease , 2007, Pediatric blood & cancer.

[31]  J. Wagner,et al.  Good manufacturing practices production of natural killer cells for immunotherapy: a six‐year single‐institution experience , 2007, Transfusion.

[32]  W. Sanger,et al.  Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[33]  M. Caligiuri,et al.  Human natural killer cell development and biology. , 2006, Blood reviews.

[34]  D. Campana,et al.  Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells. , 2005, Blood.

[35]  M. Duval,et al.  Characterization of Cord Blood Natural Killer Cells: Implications for Transplantation and Neonatal Infections , 2005, Pediatric Research.

[36]  M. Cairo,et al.  Cord blood immunology and stem cell transplantation. , 2005, Human immunology.

[37]  Jessica M Malenfant,et al.  CD107a as a functional marker for the identification of natural killer cell activity. , 2004, Journal of immunological methods.

[38]  M. Smyth,et al.  Innate Immune Surveillance of Spontaneous B Cell Lymphomas by Natural Killer Cells and γδ T Cells , 2004, The Journal of experimental medicine.

[39]  R. Koup,et al.  Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. , 2003, Journal of immunological methods.

[40]  Chan Zeng,et al.  Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[41]  Katia Perruccio,et al.  Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic Transplants , 2002, Science.

[42]  M. Caligiuri,et al.  The biology of human natural killer-cell subsets. , 2001, Trends in immunology.

[43]  R. Schreiber,et al.  IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity , 2001, Nature.

[44]  M. Anver,et al.  Opposing roles of interferon-gamma on CD4+ T cell-mediated graft-versus-host disease: effects of conditioning. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[45]  K. Nakachi,et al.  Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population , 2000, The Lancet.

[46]  S. Cohen,et al.  Analysis of the cytokine production by cord and adult blood. , 1999, Human immunology.

[47]  J. Wagner,et al.  Cord Blood Transplantation Study (COBLT): cord blood bank standard operating procedures. , 1998, Journal of hematotherapy.

[48]  J. Wagner,et al.  Placental and/or umbilical cord blood: an alternative source of hematopoietic stem cells for transplantation. , 1997, Blood.

[49]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[50]  J. Gaddy,et al.  Cord blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[51]  L. Lanier,et al.  Ontogeny of human natural killer (NK) cells: fetal NK cells mediate cytolytic function and express cytoplasmic CD3 epsilon,delta proteins , 1992, The Journal of experimental medicine.

[52]  M. Cairo,et al.  Unrelated umbilical cord blood transplantation and immune reconstitution. , 2010, Seminars in hematology.

[53]  S. Grupp,et al.  Immunotherapy for pediatric cancer. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[54]  M. Tomayko,et al.  Determination of subcutaneous tumor size in athymic (nude) mice , 2004, Cancer Chemotherapy and Pharmacology.

[55]  R. Biassoni,et al.  What is a natural killer cell? , 2002, Nature Immunology.

[56]  A. Nagler,et al.  Ex vivo expansion of CD56+ cytotoxic cells from human umbilical cord blood. , 2001, Experimental hematology.

[57]  B. Winchester.  Lysosomal membrane proteins. , 2001, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[58]  C. Biron,et al.  Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.